Endocrine Flashcards

1
Q

Diabetes
Type 1 vs Type 2
Insulin release
Insulin action

A

Autoimmune destruction of pancreatic islet cells leading to reduced insulin
Hypersecretion of insulin by depleted beta cell mass. Increasing insulin resistance

Alpha cells: glucagon, beta cells: insulin
Glucose -> beta cell. Enters via GLUT-2. Increases ATP. ATP closes K+ channels which depolarise cell. VgCa channels open Ca to cell. Insulin released.

To peripheral muscle. Binds insulin receptor. Mobilises GLUT-4 to membrane. Glucose able to enter cell.
Increase glucose -> increased insulin
Increase uptake liver (200g) and muscles (150g) as glycogen
Suppresses gluconeogenesis, lipolysis, proteolysis, ketogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Type 1 DM
Aetiology
Presentation
Complications

A

Genetic predisposition and autoimmune process (insulin/islet cell autoantibodies)
Family history of other autoimmune conditions HLA DR3/4

Polyuria, polydipsia, weight loss, lethargy, DKA problems… (dehydration, breathing, abdo pain)…

DKA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Type 2 DM
Who
RF
Pres

A

30+ obese, low physical activity

Obesity (trunk i.e. metabolic), lack of activity, PCOS, metabolic syndrome, family Hx (x2.4 > than T1DM), south Asian, pre-diabetes (impaired glucose tolerance/fasting glucose)

Polyuria, polydipsia, lethargy, prolonged/frequent/recurrent infections (e.g. vaginal thrush)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

DM
Ix
Diagnosis criteria
Complication screening (3)

A

Urine dip, FPG, RPG, OGTT, HbA1c (n.b. this won’t be accurate in anaemic patients)

Symtomatic + one elevated FPG (≥7.0) or RPG (≥11.1)
Asymptomatic + two elevated FPG or RPG
HbA1c ≥48mmol/mol or 6.5%

Urine dip for protein
BP for HTN
Fasting lipid for hyperlipidaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Diabetic foot
Presentation (2)
Risk factors

A

Ulcers (neuropathic painless and punched out or arterial), loss of pulses
Charcot foot - Bone and joint degeneration -> deformity - Rockerbottom sole, claw toes, loss of transverse arch

Peripheral neuropathy, callus smoking, HTN, hypercholesterolaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Diabetic eye problems
Types
Process
Features (5)

A

Cataracts, retinopathy, maculopathy, glaucoma

Microvascular occlusion -> retinal ischaemia -> neovascularisation
Pericyte loss -> leakage -> haemorrhages or diffuse oedema

Microaneurysm - from physical weakness
Hard exudates - lipoproteins from leakage
Haemorrhages - rupture of weakened capillaries small dots, blots or flame
Cotton wool spots - build up of axonal debris
Neovascularisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Diabetic eye problems
Presentation
Management
Emergency referrals (3)

A

Painless, gradual reduction of central vision
Haemorrhage - sudden onset dark, painless floater

Optimise glycaemic control
Blood pressure control
Lipid control
Laser photocoagulation
Or intravitreal steroids

Sudden LOV
Red eye
Retinal detachment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Annual review criteria (10)

A
Educate + modifiable RFs
Check BMI
Check complications: hypos, HOHS, DKA
Assess CVS: BP, pulses, bruits
Inspect injection sites  - lipodystrophy
Foot check - neuropathy and pulses
Urine dip - protein, nitrites, ketones
Check eyes - acuity and ophthalmoscopy -> refer opthalmology
Ask erectile dysfunction
Bloods: HbA1c and home capillary monitoring results, random lipids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Type II DM management

A

Single drug therapy ideally metformin
Target is 6.5%
Gradually increase over weeks to reduce GI SE

Dual drug therapy *only if HbA1c > 58mmol/mol or 7.5%
Target is 7% (53mmol/mol)
Sulfonylurea or pioglitazone

Still not 58/7.5%
Metformin + sulfonylurea + pioglitazone
Metformin + sulfonylurea + gliptin

Start insulin
Insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
Metformin
Class
Pharmacology
Contraindications
SE
A

Biguanide

Increases insulin sensitivity (GLUT 4), decreases gluconeogenesis

CKD, eGFR < 30

GI upset: nausea, anorexia, diarrhoea - 20% intolerable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
Sulfonylurea
Class
Pharmacology
CI
SE
A

Oral hypoglycaemics

Increase panc insulin secretion

Pregnancy

*Hypo, weight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
Piaglitazone
Class
Pharmacology
CI
SE
A

Oral hypoglycaemics

Increases insulin sensitivity

Heart failure and osteoporosis

Weight gain, fluid retention and osteoporosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Insulin regimes (4)

A

Once-daily - Long or int at bedtime - only suitable T2DM
Twice-daily - Pre breakfast/evening meal
Basal-bolus - Long or int at bedtime with rapid/short to cover meals
Continuous subcut or insulin pump- If very poor control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Sickness and Diabetes

A

Stress response to illness -> increased cortisol
Cortisol increases blood sugars and decreases insulin

If oral meds - Seek help if glucose >13mmol/l
If insulin meds - Seek help if signs of DKA (Kussmaul, vomiting, drowsy/confused, can’t eat)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DKA
Causes
Presentation (7)

A

Reduced insulin levels caused by - missed insulin, infection, intoxication, ischaemia, infarction

Abdominal pain + vomiting
Polyuria, polydipsia, dehydration
Kussmaul respiration (deep hyperventilation to correct acidosis)
Acetone breath (pear drop) (Fat -> Ketones)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DKA Ix (4)

A

Plasma glucose: high >11 or known DM
Plasma ketones: high >3mmol/l
ABG: metabolic acidosis pH < 7.3
Urine dip: ketones (++) and glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

DKA management

A

ABCDE sats etc… + catheterise

Volume depletion: IV NaCl (1L/hour or maintenance)
*switch to 5% dex when glucose <12
Hyperglycaemia: IV insulin - will drop the potassium…
*Fixed rate IV infusion: 0.1U/kg/hr add glucose when drops
Hypokalaemia (as a result of fluids and insulin): K+in fluids
>5.5 = nil
3.5-5.5 = 40mmol/L infusion solution
<3.5 = senior review
Acidaemia: IV bicarbonate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Hyperosmolar hyperglycaemic state
What
Causes
Mechanisms

A

Often very high blood glucose >40 + v.high serum osmolality. (DKA equivalent for type II DM)

Infection, MI, dehydration, inability to take normal meds, thiazides + loop, poor control

Hyperglycaemia -> osmotic diuresis -> hyperosmolarity leading to fluid shift of water into intravascular compartment -> severe dehydration
No ketosis as enough insulin to suppress ketogenesis

Hypovolaemia
Marked hyperglycaemia (>30) without hyperketonaemia or acidosis
Osmolality > 320 mosmol/kg (concentration of blood)
N.b. osmolality = /kg, osmolarity = /L
Extreme dehydration + altered mental state ± seizures ± delirium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

HHS Ix (6)

A
Urinalysis: glycosuria +++. Ketonuria +
Capillary glucose > 30
Serum osmolarity > 320mmol/L
U+E -> AKI
ABG -> normal
Blood cultures -> rule out sepsis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

HHS management

A

Treat cause
Safely normalise osmolality - replace fluid and electrolytes
Normalise blood glucose
ABCDE
IV access, ECG, SaO2, BP
Calculate osmolality frequently (2Na + gluc + urea)
-IV 0.9% NaCl -> aim for fall of Na by 10mmol/24 hours, glucose 5mmol/hr
-Aim for 3-6 litres +ve by 12 hours
IV insulin (0.05U/kg/hr) if glucose no longer falling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Rapid correction of Na

A

Cerebral oedema, central pontine myelinosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Metabolic syndrome

A

Cluster of common abnormalities including insulin resistance, impaired glucose tol, reduced HDL, elevated triglycerides and HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

BMI classification

A
≤18.5 underweight
18.5-24.9 optimal
25-29.9 overweight
30-34.9 obese I
35-39.9 obese II
≥40 obese III - weight is imminent threat
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Other causes of obesity

A

Drugs: Glitazone, sulfonylurea, antipsychotics , antidepressants: tricyclics and mirtazapine, lithium, progesterone only contraception, BB, corticosteroids

Conditions: Hypothyroid, PCOS, Cushing’s, hypogonadism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

NICE recommended calorie decrease for weight loss

A

600kcal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Gynaecomastia
Physiology
Causes

A

Oestrogens stimulate, androgens inhibit therefore ratio is important
Conditions raising oestrogen
Conditions dropping testosterone/androgen resistance
Conditions causing increased conversion of androgens to oestrogen - aromatase (in increased adiposity)

Path (low test) - androgen resistance, Klinefelter’s, viral orchitis (mumps), renal disease

High oestrogen - Neoplasms secreting HCG (e.g. seminoma), RCC, adrenal tumour (oestrogen), *liver disease - increased prod androstenedione and aromatisation to oestrogen), obesity, hyperthyroid.

Drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Drugs causing gyneacomastia (4)

A

Digoxin - oestrogen like effect (enhanced with liver failure)
Increase prolactin - antipsychotics, TCA, metoclopramide
Spironolactone - inhibit testosterone synthesis
Anabolic steroids - androgens cause high oestrogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

T3 & T4
Which active
Where activated

A

T3

80% @ liver, 20% @ thyroid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Hypothyroid
Most common cause
Associations
Other causes (3)

A

Hashimoto’s thyroiditis

AI disease: T1DM, Addison’s, pernicious anaemia: 5x in women

Iatrogenic: surgery or radioiodine treatment
Drugs: lithium, amiodarone (*iodine rich may become hypo or hyper)
Iodine deficiency most common in developing world

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Hypothyroid symptoms (8)

A
Tired + lethargic
Intolerant to cold
Slow intellectual: poor memory and difficulty concentrating
Constipation
Weight gain + decreased appetite
Deep hoarse voice
Menorrhagia
Reduced libido, depression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Signs of hypothyroid (7)

A
Dry coarse skin/hair
Puffy face/hands/feet (myxoedema)
Bradycardia
Goitre
Delayed tendon reflex
Carpal tunnel
Serous cavity effusions: pericarditis/pleural effusions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Myxoedema
Features (6)
Severe cases
Treatment

A

Due to build up of mucopolysaccharide in tissues.

Expressionless face with peri-orbital fullness
Pale cool skin with rough - doughy texture
Enlarged heart
Megacolon
Cerebellar ataxia
Psychosis + encephalopathy -> myxoedema coma

Severe cases - Hypo features + seizures + hypothermia + decreased consciousness + hypoventilation + hypoglygaemia/natremia

IV levothyroxine + IV hydrocortisone (after blood cortisone) + resp support

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Management of hypothyroid

A

Levothyroxine (T4) for life
Initial dose: 50-100 mcg, step up by 25-50 depending on TFT every 3-4 weeks

Annual TFT when stable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Hyperthyroid
Main cause
Other causes

A

Grave’s disease (assoc thyroid eye disease) - 75%

Toxic multinodular goitre - more common in >60 from high iodine (amiodarone or derbyshire)
Toxic nodule/adenoma
Drugs: amiodarone
Exogenous thyroid hormone excess: treatment
Ectopic thyroid tissue: metastatic follicular carcinoma or ovarian teratoma
TSH secreting pituitary adenoma (secondary)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Symptoms and Signs of hyperthyroid (5 each)

A
Weight loss and increased appetite
Irritable + weak
Sweating, tremor
Diarrhoea
Mental illness: anxiety to psychosis
Heat intolerant
Loss of libido
Oligomenorrhoea
Sweaty/warm palms
Fine tremor
Tachycardia ± AF
Hair thinning
Goitre
*Proximal myopathy (wasting and weakness)
Gynaecomastia
Brisk reflexes
Urticaria/pruritus + thyroid acropachy + pretibial myxoedema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Graves disease
Antibody
Pathophysiology
Thyroid eye disease features (10)

A

Anti-TSH receptor (Abs may react with orbital antigens)

AAb stimulate TSH receptor leading to excess secretion of thyroid hormones and hyperplasia of follicular cells -> diffuse goitre

Lid lag, lid retraction, ophthalmoplegia, exophthalmos, gritty eyes, diplopia, loss of colour vision, conjunctival oedema, papilloedema

Nb. Worsened by radio-iodine + smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Management of Hyperthyroid

A

Beta-blockers - propanolol
Lubricating eye drops
Antithyroid drugs
-Carbimazole: start 10-20mg/day titrate based on TFT (monthly)
-Propylthiouracil - causes liver fail: reserve for pregnancy and thyroid storm

Radioactive iodine (CI at pregnancy/breast feeding)
Relapsed Grave’s or toxic nodular (worsens eye disease in Grave’s)
Surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Warning with antithyroid drugs

A

myelosuppression - agranulocytosis + neutropenia sepsis

Usually presents as a sore throat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Thyroid storm
Happens in
Features
Cause

A

Grave’s or TMNG

Hyperpyrexia > 41
CVS: HR > 140, hypotension, AF, CHF
GI: Nausea, jaundice, vomiting, diarrhoea, abdominal pain
NEURO: Confusion, agitation, delirium
Infection

Resus: O2, IV fluids, NG tube if vomiting
- Oral carbimazole or propylthiouracil
- @4 hours - Lugol’s solution - aqueous iodine to block TH
IV propanolol
IV hydrocortisone (treats possible relative adrenal insufficiency)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

PTH physiology

A

Released in response to low ionised Ca
Actions
-To bone: increase osteoclastic activity - release Ca and PO4
-To kidney: 25-OH-D to 1,25-OH2-D (1-alpha hydroxylase) - increases Ca absorption gut
Increases reabs Ca, decreases reabs PO4 (increases PO4 in urine, decreases Ca)
-Net effect - increased Ca, decreased PO4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Calcitonin

A

Produced by para-follicular (medullary) C cells of thyroid inhibits osteoclast activity - reduces Ca and PO4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Primary hyperparathyroid
Who
Cause
Presentation

A

Occur in postmenopausal women
85% are solitary adenoma
10% are 4 gland hypertrophy

80% are asymptomatic and diagnosis when hyperCa found

Excess Ca absorption from bone: osteopenia and osteoporosis if extreme
Excessive renal Ca excretion: calculi
Mild symptoms of hypercalcaemia: fatigue, weakness, muscle pain
*Bones, stones, abdominal moans, thrones, psychic overtones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Gynaecomastia
Physiology
Causes

A

Oestrogens stimulate, androgens inhibit therefore ratio is important
Conditions raising oestrogen
Conditions dropping testosterone/androgen resistance
Conditions causing increased conversion of androgens to oestrogen - aromatase (in increased adiposity)

Path (low test) - androgen resistance, Klinefelter’s, viral orchitis (mumps), renal disease

High oestrogen - Neoplasms secreting HCG (e.g. seminoma), RCC, adrenal tumour (oestrogen), *liver disease - increased prod androstenedione and aromatisation to oestrogen), obesity, hyperthyroid.

Drugs

44
Q

Drugs causing gyneacomastia (4)

A

Digoxin - oestrogen like effect (enhanced with liver failure)
Increase prolactin - antipsychotics, TCA, metoclopramide
Spironolactone - inhibit testosterone synthesis
Anabolic steroids - androgens cause high oestrogens

45
Q

T3 & T4
Which active
Where activated

A

T3

80% @ liver, 20% @ thyroid

46
Q

Hypothyroid
Most common cause
Associations
Other causes (3)

A

Hashimoto’s thyroiditis

AI disease: T1DM, Addison’s, pernicious anaemia: 5x in women

Iatrogenic: surgery or radioiodine treatment
Drugs: lithium, amiodarone (*iodine rich may become hypo or hyper)
Iodine deficiency most common in developing world

47
Q

Hypothyroid symptoms (8)

A
Tired + lethargic
Intolerant to cold
Slow intellectual: poos memory and difficulty concentrating
Constipation
Weight gain + decreased appetite
Deep hoarse voice
Menorrhagia
Reduced libido, depression
48
Q

Signs of hypothyroid (7)

A
Dry coarse skin/hair
Puffy face/hands/feet (myxoedema)
Bradycardia
Goitre
Delayed tendon reflex
Carpal tunnel
Serous cavity effusions: pericarditis/pleural effusions
49
Q

Myxoedema
Features (6)
Severe cases
Treatment

A

Due to build up of mucopolysaccharide in tissues.

Expressionless face with peri-orbital fullness
Pale cool skin with rough - doughy texture
Enlarged heart
Megacolon
Cerebellar ataxia
Psychosis + encephalopathy -> myxoedema coma

Severe cases - Hypo features + seizures + hypothermia + decreased consciousness + hypoventilation + hypoglygaemia/natremia

IV levothyroxine + IV hydrocortisone (after blood cortisone) + resp support

50
Q

Management of hypothyroid

A

Levothyroxine (T4) for life
Initial dose: 50-100 mcg, step up by 25-50 depending on TFT every 3-4 weeks

Annual TFT when stable

51
Q

Hyperthyroid
Main cause
Other causes

A

Grave’s disease (assoc thyroid eye disease) - 75%

Toxic multinodular goitre - more common in >60 from high iodine (amiodarone or derbyshire)
Toxic nodule/adenoma
Drugs: amiodarone
Exogenous thyroid hormone excess: treatment
Ectopic thyroid tissue: metastatic follicular carcinoma or ovarian teratoma
TSH secreting pituitary adenoma (secondary)

52
Q

Symptoms and Signs of hyperthyroid (5 each)

A
Weight loss and increased appetite
Irritable + weak
Sweating, tremor
Diarrhoea
Mental illness: anxiety to psychosis
Heat intolerant
Loss of libido
Oligomenorrhoea
Sweaty/warm palms
Fine tremor
Tachycardia ± AF
Hair thinning
Goitre
*Proximal myopathy (wasting and weakness)
Gynaecomastia
Brisk reflexes
Urticaria/pruritus + thyroid acropachy + pretibial myxoedema
53
Q

Graves disease
Antibody
Pathophysiology
Thyroid eye disease features (10)

A

Anti-TSH receptor (Abs may react with orbital antigens)

AAb stimulate TSH receptor leading to excess secretion of thyroid hormones and hyperplasia of follicular cells -> diffuse goitre

Lid lag, lid retraction, ophthalmoplegia, exophthalmos, gritty eyes, diplopia, loss of colour vision, conjunctival oedema, papilloedema

Nb. Worsened by radio-iodine + smoking

54
Q

Management of Hyperthyroid

A

Beta-blockers - propanolol
Lubricating eye drops
Antithyroid drugs
-Carbimazole: start 10-20mg/day titrate based on TFT (monthly)
-Propylthiouracil - causes liver fail: reserve for pregnancy and thyroid storm

Radioactive iodine (CI at pregnancy/breast feeding)
Relapsed Grave’s or toxic nodular (worsens eye disease in Grave’s)
Surgery

55
Q

Warning with antithyroid drugs

A

myelosuppression - agranulocytosis + neutropenia sepsis

Usually presents as a sore throat

56
Q

Thyroid storm
Happens in
Features
Cause

A

Grave’s or TMNG

Hyperpyrexia > 41
CVS: HR > 140, hypotension, AF, CHF
GI: Nausea, jaundice, vomiting, diarrhoea, abdominal pain
NEURO: Confusion, agitation, delirium
Infection

Resus: O2, IV fluids, NG tube if vomiting
- Oral carbimazole or propylthiouracil
- @4 hours - Lugol’s solution - aqueous iodine to block TH
IV propanolol
IV hydrocortisone (treats possible relative adrenal insufficiency)

57
Q

PTH physiology

A

Released in response to low ionised Ca
Actions
-To bone: increase osteoclastic activity - release Ca and PO4
-To kidney: 25-OH-D to 1,25-OH2-D (1-alpha hydroxylase) - increases Ca absorption gut
Increases reabs Ca, decreases reabs PO4 (increases PO4 in urine, decreases Ca)
-Net effect - increased Ca, decreased PO4

58
Q

Calcitonin

A

Produced by para-follicular (medullary) C cells of thyroid inhibits osteoclast activity - reduces Ca and PO4

59
Q

Primary hyperparathyroid
Who
Cause
Presentation

A

Occur in postmenopausal women
85% are solitary adenoma
10% are 4 gland hypertrophy

80% are asymptomatic and diagnosis when hyperCa found

Excess Ca absorption from bone: osteopenia and osteoporosis if extreme
Excessive renal Ca excretion: calculi
Mild symptoms of hypercalcaemia: fatigue, weakness, muscle pain
*Bones, stones, abdominal moans, thrones, psychic overtones

60
Q

Management of hyperparathyroid

A

Mild hypercalcaemia + minimal kidney stones - surveillance
-Check creatinine and Ca 6 months
-DEXA yearly
Vitamin D *suppresses PTH
Avoid dehydration, thiazide diuretics - increase fluids
Surgery if symptomatic
Bisphosphonates (alendronate)
Cinacalcet (calcimimetic) reduces serum Ca and PTH levels and raises PO4 (no effect on bone turnover

61
Q

Types of hyperparathyroid, cause & PHT/Ca/PO4 levels

A

Primary - solitary adenoma at PTH glands (85%) postmenopausal women - High PTH, high Ca, low phosphate

Secondary - as a result of low calcium - PT gland hyperplasia, *almost always associated with kidney, liver or bowel disease - High PTH, low Ca, high phosphate, low vitamin D

Tertiary - ongoing hyperplasia of PT glands after correction of underlying renal disorder CKD . i.e. after prolonged secondary hyperplasia of all 4 glands - High PTH, high Ca, high phosphate, normal vitamin D, high alk phos (separates from primary)

62
Q

Types of hypoparathyroid

A

Primary hypothyroidism
-Congenital - DiGeorge, defect in PTH gene, defect in Calcium sensing
Acquired - Neck surgery, neck irradiation, alcohol, iron deposition (haemochromatosis), copper (Wilson’s), magnesium deficiency or excess

Pseudohypoparathyrodism - defect in PTH action and end-organ resistance to PTH
Low IQ, short stature, short 4th and 5th metacarpals
Low Ca, high PO4, high PTH (but fail action)

Pseudopseudohypoparathyroidism
Similar phenotype to above but normal biochemistry

63
Q

Hypoparathyroid Ix

A

Low Ca, high PO4, low PTH, normal alk phos (@ pseudohypoparathyroidism = low Ca, high PO4, high PTH)
U+E - to exclude CKD
25-hydroxyvitamin D3 to exclude vitamin D deficiency as cause of hypocalcaemia
ECG - prolonged QT (hypocalcaemia)

64
Q

Hypoparathyroid treatment

A

If tetany - urgent IV Ca
Diet: rich in Ca and vit D
Calcium and vit D

65
Q

Anterior vs posterior pituitary

A

GH: stimulates liver to produce IGF-1 and counteracts insulin
Prolactin: promotes growth of mammary glands and reproductive organs
FSH: stimulates release of sex steroids
LH: stimulates release of sex steroids
ACTH: adrenocorticotropic hormone: stimulates adrenal cortex to release glucocorticoids and androgens
TSH

Vasopressin - Role in water re absorption.
Oxytocin - Social bonding, sexual reproduction, and ejection of breast milk

66
Q

Nerves in the cavernous sinus

Local effects of pituitary masses (3)

A

Cavernous sinus = CN 3, 4, 5a, 5b, 6
Optic chiasm - Visual field defect: bitemporal hemianopia
Headaches: retro-orbital and bilateral worse on waking
Ocular nerve palsies - squint

67
Q

Presentation of hypopituitary

A

LH/FSH - Infertility/oligomenorrhoea, erectile dysfunction, loss of libido
GH - Short stature in kids
Prolactin - Inappropriate milk secretion
Long standing - loss of muscle bulk and body hair

68
Q

Craniopharyngioma

A

Benign and cystic growth of pituitary gland (grows down = lose bottom half vision) most common childhood IC neoplasm. Headache + visual field defects + hypopituitarism

69
Q

Syndromes associated with hypopituitism (3)

A

Kallmans - Deficiency in GnRH - Associated with anosmia
Sheehans syndrome - Pituitary infarction in post partum haemorrhage
Pituitary apoplexy - Rapid enlargement due to bleed into tumour -> mass effect, CV collapse and acute hypopituitarism

70
Q

Pituitary apoplexy
Ix
Management

A

Serum cortisol, LH/FSH, IGF Prolactin, TSH, testosterone/oestradiol.
FBC, clotting, U&E
Visual fields
MRI

Fluids to ensure heamodynamically stable
Hydrocortisone IV
Surgery

71
Q

Effects of prolactin
Women
Men

A

Women - inhibits GNRH -> reduced gonadotropin (FSH + LH) secretion -> menstrual dysfunction + galactorrhoea -> low oestrogen

Men - direct reversible response on hypothalamus -> secondary hypogonadism -> decreased libido and ED

72
Q

Causes of hyperprolacinameia

A

Prolactinoma - benign MICROadenoma
Hypothyroid -> raises TSH -> stimulates release of PRL
Other endocrine = Cushing’s syndrome
Antipsychotics -> block dopamine -> raise PRL
-Dopamine receptor antag: domperidone, metoclopramide, neuroleptics
-Dopamine depleting: methyldopa
-Antidepressants: e.g. TCA, MAOI, SRI
Physiological - pregnancy, puerperium, stress, exercise
Head injury

73
Q

Hyperprolacinameia presentation

A

Women: oligomenorrhoea, amenorrhoea, galactorrhoea, infertility, hirsutism
Men: slower pres, reduced libido, reduced beard growth, ED
Children: growth failure and delayed puberty

74
Q

Hyperprolacinameia teatment

Side effects

A

Dopamine agonist - Bromocriptine

SE: sleepiness, hypotension, cardiac/retroperitoneal/pulmonary fibrosis - monitor

75
Q

Acromegaly vs Giantism

Cause

A
Acromegaly = overgrowth of all organ systems bones, joints and soft tissues by IGF1
Giantism = excess GH or IGF1 before closure of epiphyseal plates

Usualy MACROadenoma - Hence visual defects.

Nb. IGF1 is main tissue mediator of GH

76
Q

Acromegaly presentation

A

Due to size: headaches (55%), visual field defect (bitemporal hemianopia)

Excess GH:
Change in appearance: enlarge hands and feet (ring and shoe size), frontal bossing, thickened nose, coarsening facial features
Change in mouth: macroglossia - OSA and snoring
Change in skin: dark thick oily skin + sweating (65%)
Articular overgrowth: arthralgia, osteoarthritis, jaw pain
Nerve compression: bilateral carpal tunnel (50%) - IGF mediated hypertrophy, acroparasthesia (extremities)
Visceral hypertrophy: cardio/hepatomegaly
Cardiac features: HTN, arrhythmia, LVH
T2DM and glucose intolerance due to insulin resistance

Features of hyperprolacinaemia - Amenorrhea, Galactorrhea, poor libedo

77
Q

GH inhibited by?

A

High glucose levels & somatostatin

78
Q

Ix in acromegaly

A

Serum IGF1 - raised, correlates with GH, long half life, stable serum -> therefore choice, may be affected by liver disease
OGTT to confirm a raised IGF
-75g glucose load
-Failure to suppress to < 0.4mcg/L

79
Q

Management of acromegaly

A

First line: transsphenoidal surgery
Second line: SS analogues: Ocreotide/lanreotide: SE abdominal cramps
Third line: dopamine agonists, cabergoline (safe at preg), bromocriptine

80
Q

Complications of acromegaly

A

Cardiac complications: 40%
-LVH, arrhythmia - monitor with ECG and echo
-HTN
Sleep apnoea
Diabetes
Carpal tunnel: improves with Rx of acromegaly
Increased risk colon cancer: monitor every 3-5 years

81
Q

Adrenal secretions

A

The deeper you get the sweeter it gets - Salt, Sugar, Sex

Zona glomerulosa - mineralocorticoids - aldosterone
Zona fasciculata - glucocorticoids - cortisol
Zona reticularis - androgens - DHEA - dehydroepiandrosterone

82
Q

Effects of Cortisol (5)

Diurnal variation?

A
RIDGE
Suppression of reproduction
Suppression of immunity
Suppression of digestion
Suppression of growth
Mobilisation of energy -> elevated sugars 

Diurnal variation - highest at morning, lowest at midnight

83
Q

Cushings SYNDROME
What
Types

A

Prolonged exposure to exogenous or endogenous glucocorticoids with clinical state of increased free cortisol and loss of negative feedback

ACTH independent
-Adrenal adenoma/adrenal carcinoma/excess glucocorticoids

ACTH dependent
-Excessive ACTH pit (Cushing’s disease), ectopic ACTH producing tumours (due to lung cancer, small cell)

84
Q

Cushings syndrome features (8)

A

Truncal obesity, buffalo hump, weight gain
Facial fullness, moon face
Proximal muscle wasting
Diabetes or impaired GT: polyuria, polydipsia
Hypertension
Osteoporosis
Infection prone and poor healing
Mood change: depression, lethargy, irritable, psychosis
Skin: atrophy, purple striae, easy bruising, hirsutism, acne, pigmentation, acne

85
Q

Cushings syndrome Ix

A

Serum glucose: elevated
First line: 1mg overnight dexamethasone suppression test, measure cortisol 8am - Failure to suppress to <50nmol/L = +ve
24 hour urinary free cortisol: high (x3) should be high in 2/3 samples

Second line: 48 hour 2mg dexamethasone suppression test, failure to suppress to <50nmol/L

Localisation - Plasma ACTH
if low = adrenal = CT adrenal
If high = likely pituitary.

86
Q

Cushings syndrome complications (4)

A

CV disease: main cause of death: HTN, DM, dyslipidemia
Metabolic syndrome, HTN, T2DM
Impaired immunity
Osteoporosis

87
Q

Addisons
What
Types
Antibody

A

Destruction of adrenal cortex and subsequent reduction in output of adrenal hormones: glucocorticoids (cortisol), and mineralocorticoids (aldosterone)

Primary: Addison’s - inability of adrenal glands to produce steroid - autoimmune
Addison’s 85%
Surgical
Metabolic failure: CAH e.g. 21-hydroxylase deficiency

Secondary: Inadequate pituitary stimulation of adrenal glands, exogenous steroids
Steroids suppress axis
CRH deficiency

Anti-21 hydroxylase (85%)

88
Q
Addisons Symtoms (5Ts)
Signs
A

Chronic: thin, tanned, tired, tearful and tumbling

Fatigue and weakness
GI: Anorexia, nausea, vomiting, weight loss
Cravings for salt and salty food
Muscle cramps
Faintness due to hypotension
Mood: confusion, personality change, irritable

Signs: pigmental palmar crease and buccal mucosa, hypotension, postural hypotension

89
Q

Addisons Ix

Confimation test

A

Sodium - low, potassium - high (by low aldosterone, low ENaC and ROMK)
Glucose - low in children (low cortisol)
Cortisol levels - highest @ 8am, if 100-150nmol/L = further investigation, <100 = urgent admission
ACTH levels - for differentiate primary or secondary
High = primary, low = secondary
Renin and aldosterone (high renin and low aldosterone in Addison’s)
Anti 21-hydroxylase (n.b. @ CAH = 21 hydroxylase deficiency)

Short synacthen test:
Take cortisol level
Give 250 mcg synacthen IM (synth ACTH). In 30 mins retake cortisol
If cortisol rises then exclude Addison’s >500nmol/L

90
Q

Addisons management

A

Glucocorticoid: hydrocortisone - TDS, highest dose at morning 15-30mg
- In illness may increase x 3, double in intercurrent illness
Mineralocorticoid: Fludrocortisone: 50-300 mcg/day will correct postural hypotension and electrolyte imbalance

91
Q
Addisonian crisis
What
Precipiants
Symptoms
Signs
Management
A

Acute deficiency of glucocorticoid cortisol and mineralocorticoid

Major or minor infx, commonly vom/diarrhoea, injury, surgery, pregnancy

Malaise, fatigue, nausea/vomiting, low-grade fever, muscle cramps, confusion

Dehydration: hypotension and hypovolaemic shock
Low Na, high K, Cr raised, hypoglycaemia, bloods for cortisol and ACTH

IV/IM hydrocortisone (*100mg adult) n.b. At high dose hydrocortisone has mineralocorticoid effect
Rehydration - fluids
Further hydrocortisone + glucose: 100mg in 5% over 24 hours
Continuous cardiac and electrolyte monitoring (ECG, reg U+E)
Treatment of infx (IV ABX)

92
Q

Conns
What
Causes

A

Excess production of aldosterone independent of RAAS system due to adrenal adenoma - > renin is suppressed

Primary
-Adrenal adenoma in 80%
-Bilateral adrenal hyperplasia in 20%
Secondary - due to high renin from decreased renal perfusion in renal artery stenosis

93
Q

Conns presentation

A

Oedema
Hypertension
Hypokalaemia - weakness, cramps, parasthesia
Metabolic alkalosis - secretion of H+ in exchange for K+ (more K+ in urine) in intercalated cells

94
Q

Conns Ix

A
U+E: hypernatraemia, hypokalaemia
BP: high
*Aldosterone: renin ratio (high ald, low renin - normal renin exludes Dx)
>800 = imaging required
ECG for arrhythmia
CT/MRI for adrenal adenoma
95
Q

Conns magement

A
Medical management prior to surgery:
4 weeks spironolactone (aldosterone antagonist)
Laparoscopic adrenalectomy (only if unilateral)
BAH: aldosterone antagonists
Spironolactone (blocks aldosterone and testosterone = may lead to gynaecomastia, ED and menstrual problems)
96
Q
Phaeochromocytoma
What
Main complications
Presentation (4)
Signs
A

Catecholamine producing adrenal tumour @ adrenal medulla. Secrete autonomously from SNS

Life threatening HTN, cardiac arrhythmia

Episodic headache + sweating + palpitations + tremor

Hypertension, postural hypotension, tremor, flushing, tachycardia

97
Q

Phaeochromocytoma
Ix
Management

A

24 hour urine catecholamines, metanephrines, VMA
Raised serum metanephrines
Abdominal CT/MRI

Phentolamine or IV nitroprusside
Definitive is sugery

98
Q
Adrenergic receptors blockade  
A1
A2
B1
B2
A

SM @ BV = reduces BP, SM contraction @ bladder neck = increased peeing

Inhibit insulin release @ pancreas = more insulin

Tachycardia + increased contractility -> decrease HR + CO
Increased renin release -> decreased renin

Bronchodilation -> bronchoconstriction

99
Q

Carcinoid
What
Presentation
Which tumours more likely

A

Tumour of enterochromaffin cell secreting serotonin, other vasoactive peptides

Flushing and diarrhoea
Wheeze, palpitations, telangiectasia, abdominal pain

30% of gut, 5% of bronchial

100
Q

Diabetes insipidus
Types
What
Value

A

Nephrogenic or cranial

Passage of large amounts of dilute urine due to hyposecretion or resistance to ADH/vasopressin (same thing) and inability to concentrate urine

3l of <300mOsm/kg

101
Q

Causes of DI
Cranial
Nephrogenic

A

Damage to hypothalamus
Acquired: idiopathic, tumour (e.g. craniopharyngioma), intracranial surgery, head injury, granulomatous disease (sarcoid, TB, GPA), infection (men, enceph)
Inherited: AD vasopressin gene

Acquired: hypokalaemia, CKD, lithium, RTA, hypercalcaemia
Inherited: X linked mut V2 ADH receptor gene, AR AQP2 gene

102
Q

DI Ix (5)

A

24 hour urine collection >3l
Urine osmolality <300mOsm/kg (2[Na+K] + urea + glucose)
Serum osmolality: normal or high (normal/high sodium, calcium, potassium)
Urine dip: -ve for glucose
*Water deprivation test with *desmopressin response

103
Q

DI Mx

A

Cranial: desmopressin replacement (Overdose = hyponatraemia)
Nephrogenic: ensure drink adequate fluid in response to thirst, stop causative drugs, treat underlying disease e.g. hypoK, hyperCa
Low sodium: either dietary or with thiazide + NSAID

104
Q

SIADH
What
Causes
Complications

A

Hyponatremia and hypo-osmolality resulting from inappropriate, continued secretion or action of the antidiuretic hormone arginine vasopressin

Pulmonary processes: pneumonia, lung cancer (esp small cell)
CNS disorders: infection, trauma, MS, haemorrhage, malignancy
Malignancy: lung, GI, GU, lymphoma
Drugs: SSRIs, NSAIDs, chemo drugs

Central pontine myelinolysis

105
Q

Ix for SIADH

A

Na - low < 135 & Urine Na high
Serum osmolality - low <280 proportional to hyponatraemia
Urine osmolality - >100mOsm/kg - typically higher than plasma
Indicate elevated AVP
Normal renal and adrenal function
Serum sodium will not respond to normal saline infusion

106
Q

Mx of SIADH

A

Acute (<48) + severe (<125)
IV hypertonic saline (3%) and check Na every 2 hours
Aim to increase 1-2 per hour until neurological symptoms resolve
+ treat cause + furosemide if risk of fluid overload

Chronic + severe
IV hypertonic saline
Vasopressin receptor antagonist tolvaptan + cause + furosemide